AAPACN is dedicated to supporting post-acute care nurses provide quality care.

FDA News: Addressing Naloxone Availability for Residents With Opioid Use Disorder (9/22)

The FDA published the FDA Voices: “FDA Issues New Guidance to Help Facilitate Availability of Naloxone to Prevent Opioid Overdoses and Reduce Death,” by Marta Sokolowska, Ph.D., Deputy Center Director for Substance Use and Behavioral...

Oops! This is member-only content.

Please login, sign up for a full membership, or sign up for a free 30-day trial membership to access this content.